157 related articles for article (PubMed ID: 11507714)
1. High-performance liquid chromatographic assay for glucuronidation activity of 7-ethyl-10-hydroxycamptothecin (SN-38), the active metabolite of irinotecan (CPT-11), in human liver microsomes.
Hanioka N; Jinno H; Nishimura T; Ando M; Ozawa S; Sawada J
Biomed Chromatogr; 2001 Aug; 15(5):328-33. PubMed ID: 11507714
[TBL] [Abstract][Full Text] [Related]
2. Determination of UDP-glucuronosyltransferase UGT1A6 activity in human and rat liver microsomes by HPLC with UV detection.
Hanioka N; Jinno H; Tanaka-Kagawa T; Nishimura T; Ando M
J Pharm Biomed Anal; 2001 Apr; 25(1):65-75. PubMed ID: 11274859
[TBL] [Abstract][Full Text] [Related]
3. An analytical method for irinotecan (CPT-11) and its metabolites using a high-performance liquid chromatography: parallel detection with fluorescence and mass spectrometry.
Sai K; Kaniwa N; Ozawa S; Sawada J
Biomed Chromatogr; 2002 May; 16(3):209-18. PubMed ID: 11920947
[TBL] [Abstract][Full Text] [Related]
4. Differential rates of glucuronidation for 7-ethyl-10-hydroxy-camptothecin (SN-38) lactone and carboxylate in human and rat microsomes and recombinant UDP-glucuronosyltransferase isoforms.
Tallman MN; Ritter JK; Smith PC
Drug Metab Dispos; 2005 Jul; 33(7):977-83. PubMed ID: 15833930
[TBL] [Abstract][Full Text] [Related]
5. [Effect of tacrolimus on the pharmacokinetics and glucuronidation of SN-38, an active metabolite of irinotecan].
Tanaka Y; Katoh M; Fujioka M; Onishi K; Sakakibara Y; Hasegawa T; Nadai M
Yakugaku Zasshi; 2013; 133(4):463-71. PubMed ID: 23328499
[TBL] [Abstract][Full Text] [Related]
6. High-performance liquid chromatography method for determination of N-glucuronidation of 4-aminobiphenyl by mouse, rat, and human liver microsomes.
Al-Zoughool M; Talaska G
Anal Biochem; 2005 May; 340(2):352-8. PubMed ID: 15840509
[TBL] [Abstract][Full Text] [Related]
7. Carboxylesterase and UDP-glucuronosyltransferases mediated metabolism of irinotecan: In vitro and in vivo insights from quantitative ultra-performance liquid chromatography-mass spectrometry analysis.
Qin Y; Kang A; Zhou G; Wang H; Wei W; Cao Y; Chen Y; Wang J; Shi Y; Tang Y; Jiang J
Biomed Chromatogr; 2018 Oct; 32(10):e4320. PubMed ID: 29920713
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous determination of bilirubin and its glucuronides in liver microsomes and recombinant UGT1A1 enzyme incubation systems by HPLC method and its application to bilirubin glucuronidation studies.
Ma G; Lin J; Cai W; Tan B; Xiang X; Zhang Y; Zhang P
J Pharm Biomed Anal; 2014 Apr; 92():149-59. PubMed ID: 24525562
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of an UPLC-MS/MS method for the quantification of irinotecan, SN-38 and SN-38 glucuronide in plasma, urine, feces, liver and kidney: Application to a pharmacokinetic study of irinotecan in rats.
Basu S; Zeng M; Yin T; Gao S; Hu M
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Mar; 1015-1016():34-41. PubMed ID: 26894853
[TBL] [Abstract][Full Text] [Related]
10. High-performance liquid chromatographic method for the simultaneous determination of the camptothecin derivative irinotecan hydrochloride, CPT-11, and its metabolites SN-38 and SN-38 glucuronide in rat plasma with a fully automated on-line solid-phase extraction system, PROSPEKT.
Kurita A; Kaneda N
J Chromatogr B Biomed Sci Appl; 1999 Mar; 724(2):335-44. PubMed ID: 10219676
[TBL] [Abstract][Full Text] [Related]
11. Simple and rapid determination of irinotecan and its metabolite SN-38 in plasma by high-performance liquid-chromatography: application to clinical pharmacokinetic studies.
Escoriaza J; Aldaz A; Castellanos C; Calvo E; Giráldez J
J Chromatogr B Biomed Sci Appl; 2000 Apr; 740(2):159-68. PubMed ID: 10821401
[TBL] [Abstract][Full Text] [Related]
12. High-performance liquid chromatographic assay with fluorescence detection for the simultaneous measurement of carboxylate and lactone forms of irinotecan and three metabolites in human plasma.
Owens TS; Dodds H; Fricke K; Hanna SK; Crews KR
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 May; 788(1):65-74. PubMed ID: 12668072
[TBL] [Abstract][Full Text] [Related]
13. A sensitive and rapid liquid chromatography tandem mass spectrometry method for quantitative determination of 7-ethyl-10-hydroxycamptothecin (SN-38) in human plasma containing liposome-based SN-38 (LE-SN38).
Khan S; Ahmad A; Ahmad I
Biomed Chromatogr; 2003 Dec; 17(8):493-9. PubMed ID: 14648604
[TBL] [Abstract][Full Text] [Related]
14. A new UPLC-MS/MS method for the determination of irinotecan and 7-ethyl-10-hydroxycamptothecin (SN-38) in mice: application to plasma and brain pharmacokinetics.
Goldwirt L; Lemaitre F; Zahr N; Farinotti R; Fernandez C
J Pharm Biomed Anal; 2012 Jul; 66():325-33. PubMed ID: 22551773
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a high-performance liquid chromatography-tandem mass spectrometry method for the simultaneous determination of irinotecan and its main metabolites in human plasma and its application in a clinical pharmacokinetic study.
Marangon E; Posocco B; Mazzega E; Toffoli G
PLoS One; 2015; 10(2):e0118194. PubMed ID: 25689738
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of an ultra-high performance LC-MS/MS assay for intracellular SN-38 in human solid tumour cell lines: comparison with a validated HPLC-fluorescence method.
Ghazaly E; Perry J; Kitromilidou C; Powles T; Joel S
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Oct; 969():213-8. PubMed ID: 25195021
[TBL] [Abstract][Full Text] [Related]
17. Glucuronidation of 7-ethyl-10-hydroxycamptothecin (SN-38), an active metabolite of irinotecan (CPT-11), by human UGT1A1 variants, G71R, P229Q, and Y486D.
Jinno H; Tanaka-Kagawa T; Hanioka N; Saeki M; Ishida S; Nishimura T; Ando M; Saito Y; Ozawa S; Sawada J
Drug Metab Dispos; 2003 Jan; 31(1):108-13. PubMed ID: 12485959
[TBL] [Abstract][Full Text] [Related]
18. Determination of irinotecan, SN-38 and SN-38 glucuronide using HPLC/MS/MS: Application in a clinical pharmacokinetic and personalized medicine in colorectal cancer patients.
Atasilp C; Chansriwong P; Sirachainan E; Reungwetwattana T; Puangpetch A; Prommas S; Sirilerttrakul S; Rerkarmnuaychoke B; Wongwaisayawan S; Sukasem C
J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28393405
[TBL] [Abstract][Full Text] [Related]
19. Panipenem does not alter the pharmacokinetics of the active metabolite of irinotecan SN-38 and inactive metabolite SN-38 glucuronide (SN-38G) in rats.
Kato A; Ueyama J; Abe F; Hotta K; Tsukiyama I; Oshima T; Kondo F; Saito H; Hasegawa T
Anticancer Res; 2011 Sep; 31(9):2915-22. PubMed ID: 21868538
[TBL] [Abstract][Full Text] [Related]
20. Fast liquid chromatography-tandem mass spectrometry method for routine assessment of irinotecan metabolic phenotype.
Corona G; Elia C; Casetta B; Toffoli G
Ther Drug Monit; 2010 Oct; 32(5):638-46. PubMed ID: 20683392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]